![Чудовище / The Monster [= Пятый вид: Загадочное чудовище; Воскресшее чудовище; Возрождение] - Альфред Ван Вогт](https://cdn.rusbook.su/s20/5/6/7/3/8/56738.jpg)
Первая клетка. И чего стоит борьба с раком до последнего - Азра Раза
Шрифт:
Интервал:
Закладка:
Yip-Williams J. The Unwinding of the Miracle: A Memoir of Life, Death, and Everything That Comes After. New York: Random House, 2019.
Carrel A. On the Permanent Life of Tissues Outside of the Organism. Journal of Experimental Medicine. 15, no. 5 (1912): 516–528.
Friedman D. M. The Immortalists: Charles Lindbergh, Dr. Alexis Carrel, and Their Daring Quest to Live Forever. New York: Ecco/HarperCollins, 2007.
Hayflick L. Mortality and Immortality at the Cellular Level: A Review. Biochemistry (Moscow). 62, no. 11 (1997): 1180–1190.
Hayflick L. The Limited In Vitro Lifetime of Human Diploid Cell Strains. Experimental Cell Research. 37, no. 3 (1965): 614–636.
Scherer W. F. et al. Studies on the Propagation In Vitro of Poliomyelitis Viruses, IV: Viral Multiplication in a Stable Strain of Human Malignant Epithelial Cells (Strain HeLa) Derived from an Epidermoid Carcinoma of the Cervix. Journal of Experimental Medicine. 97, no. 5 (1953): 695–710.
Macville M. et al. Comprehensive and Definitive Molecular Cytogenetic Characterization of HeLa Cells by Spectral Karyotyping. Cancer Research. 59, no. 1 (1999): 141–150.
Landry J. J. et al. The Genomic and Transcriptomic Landscape of a HeLa Cell Line. G3: Genes, Genomes, Genetics. 3, no. 8 (2013): 1213–1224.
Skloot R. The Immortal Life of Henrietta Lacks. New York: Crown/Random House, 2010. [Склут Р. Бессмертная жизнь Генриетты Лакс. М.: Карьера-Пресс, 2012.]
Ben-David U. et al. Genetic and Transcriptional Evolution Alters Cancer Cell Line Drug Response. Nature. 560 (2018): 325–330.
Gillet J.-P. et al. The Clinical Relevance of Cancer Cell Lines. Journal of the National Cancer Institute. 105, no. 7 (2013): 452–458.
Capes-Davis A. et al. Check Your Cultures! A List of Cross-Contaminated or Misidentified Cell Lines. International Journal of Cancer. 127, no. 1 (2010): 1–8.
Wilding J. L., Bodmer W. F. Cancer Cell Lines for Drug Discovery and Development. Cancer Research. 74, no. 9 (2014): 2377–2384.
Kolata G. Hope in the Lab: A Special Report – A Cautious Awe Greets Drugs That Eradicate Tumors in Mice. New York Times, May 3, 1998.
EntreMed Stock Rides Wave of Optimism About 2 Drugs. Los Angeles Times, May 5, 1998. www.latimes.com/archives/la-xpm-1998-may-05-fi-46397-story.html
Background on the History of the Mouse. National Human Genome Research Institute. December 2002. www.genome.gov/10005832/background-on-the-history-of-the-mouse
Ericsson A. C. et al. A Brief History of Animal Modeling. Missouri Medicine. 110, no. 3 (2013): 201–205.
Pound P. et al. Where Is the Evidence That Animal Research Benefits Humans? BMJ. 328, no. 7438 (2004): 514–517.
Talmadge J. E. et al. Murine Models to Evaluate Novel and Conventional Therapeutic Strategies for Cancer. American Journal of Pathology. 170, no. 3 (2007): 793–804.
Perlman R. L. Mouse Models of Human Disease. Evolution, Medicine and Public Health. 2016, no. 1 (2016): 170–176.
Eruslanov E. B. et al. Mouse Versus Human Neutrophils in Cancer – A Major Knowledge Gap. Trends in Cancer. 3, no. 2 (2017): 149–160.
Day C. P. et al. Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges. Cell. 163, no. 1 (2015): 39–53.
Shoemaker R. H. et al. Development of Human Tumor Cell Line Panels for Use in Disease-Oriented Drug Screening. Progress in Clinical and Biological Research. 276 (1988): 265–286.
Monks A. et al. Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines. Journal of the National Cancer Institute. 83 (1991): 757–766.
Monks A. et al. The NCI Anti-Cancer Drug Screen: A Smart Screen to Identify Effectors of Novel Targets. Anti-Cancer Drug Design. 12 (1997): 533–541.
Greve M. R. et al. The National Cancer Institute: Cancer Drug Discovery and Development Program. Seminars in Oncology. 19 (1992): 622–638.
Seok J. Genomic Responses in Mouse Models Poorly Mimic Human Inflammatory Diseases. PNAS. 110, no. 9 (2013): 3507–3512.
Begley C. G., Ellis L. M. Drug Development: Raise Standards for Preclinical Cancer Research. Nature. 483, no. 7391 (2012): 531–533.
Santarpia L. et al. Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer. Oncologist. 21 (2016): 1063–1078.
DeVita V. T., Jr., Chu E. A History of Cancer Chemotherapy. Cancer Research. 68 (2008): 8643–8653.
Sharpless N. E., Depinho R. A. The Mighty Mouse: Genetically Engineered Mouse Models in Cancer Drug Development. Nature Reviews Drug Discovery. 5 (2006): 741–754.
Ben-David U. et al. Patient-Derived Xenografts Undergo Mouse-Specific Tumor Evolution. Nature Genetics. 49, no. 11 (2017): 1567–1575.
Izumchenko E. et al. Patient-Derived Xenografts Effectively Capture Responses to Oncology Therapy in a Heterogeneous Cohort of Patients with Solid Tumors. Annals of Oncology. 28, no. 10 (2017): 2595–2605.
Tentler J. J. et al. Patient-Derived Tumour Xenografts as Models for Oncology Drug Development. Nature Reviews Clinical Oncology. 9, no. 6 (2012): 338–350.
Willyard C. The Mice with Human Tumours: Growing Pains for a Popular Cancer Model. Nature. 560, no. 7717 (2018): 156–157.
Van der Worp H. B. et al. Can Animal Models of Disease Reliably Inform Human Studies? PLOS Medicine. 7, no. 3 (2010): e1000245.
Francia G., Kerbel R. S. Raising the Bar for Cancer Therapy Models. Nature Biotechnology. 28 (2010): 561–562.
Ledford H. Cancer-Genome Study Challenges Mouse ‘Avatars.’ Grafting Human Cancer Cells into Mice Alters Tumour Evolution. Nature, October 9, 2017. doi:10.1038/nature.2017.22782.
NCI Awards Champions Oncology $ 2M SBIR Grant for Prostate Cancer Research. Genome Web. www.genomeweb.com/business-policy-funding/nci-awards-champions-oncology-2m-sbir-grant-prostate-cancer-research#.YbCuO9BBzIV
Cancer Drug Benefits Are Overhyped. Dying for a Cure, June 5, 2016.
http://dyingforacure.org/blogs/cancer-drug-benefits-overhyped/
Rubin E. H., Gilliland D. G. Drug Development and Clinical Trials – The Path to an Approved Cancer Drug. Nature Reviews Clinical Oncology. 9 (2012): 215–222.
Pharmaceutical Companies Acknowledge the Failure of Animal Models in Their Drug Development Process, and Write About This Openly in the Scientific Literature. For Life on Earth. www.forlifeonearth.org/wp-content/uploads/2013/05/Pharmaceutical-Company-Quotes2.pdf
Pippin J. J. The Failing Animal Research Paradigm for Human Disease. Independent Science News, May 20, 2014.
O’Rourke M. Doctors Tell Al l – And It’s Bad. Atlantic, November 2014.
Gawande A. Being Mortal. New York: Metropolitan Books, 2014.
[Гаванде А. Все мы смертны. М.: АСТ, 2018.]
Cochran J. The Doctor Crisis. New York: PublicAffairs, 2014.
Jauhar S. Doctored: The Disillusionment of an American Physician. New York: Farrar, Straus and Giroux, 2015.
Глава 2. ПерBuchanan M. Ubiquity: The Science of History… or Why the World Is Simpler Than We Think. New York: Crown, 2001.
Bak P. How Nature Works. Oxford, UK: Oxford University Press, 1996.
Weinberg R. One Renegade Cell: The Quest for the Origins of Cancer. New York: Basic Books, 1998.
Mehta S. Fire in the Belly: A Batch of Chili Proves Life-Affirming in More Ways Than One. Saveur, September 27, 2010. www.saveur.com/article/Kitchen/Fire-in-the-Belly
Gibbs W. W. Untangling the Roots of Cancer. Scientific American, July 1, 2008. www.scientificamerican.com/article/untangling-the-roots-of-cancer-2008–07
Weinberg R. How Cancer Arises. Scientific American, September 1996. www.scientificamerican.com/article/how-cancer-arises
Mukherjee S. The Emperor of All Maladies: A Biography of Cancer. New York: Scribner, 2010. [Мукерджи С. Царь всех болезней. Биография рака. М.: АСТ, 2013.]
Danaei G. et al. Comparative Risk Assessment Collaborating Group (Cancers). Causes of Cancer in the World: Comparative Risk Assessment of Nine Behavioural and Environmental Risk Factors. Lancet. 366, no. 9499 (2005): 1784–1793.
Mukherjee S. The Gene: An Intimate History. New York: Scribner, 2016.
Zur Hausen H. Condylomata Acuminata and Human Genital Cancer. Cancer Research. 36 (1976): 794.
Poiesz B. J. et al. Detection and Isolation of Type C Retrovirus Particles from Fresh and Cultured Lymphocytes of a Patient with Cutaneous T-Cell Lymphoma. PNAS. 77, no. 12 (1980): 7415–7419.
Gallo R. C. History of the Discoveries of the First Human Retroviruses: HTLV-1 and HTLV-2. Oncogene. 24 (2005): 5926–5930.
Moore P. S., Chang Y. Why Do Viruses Cause Cancer? Highlights of
